第一单位：
Multicentre Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) Group and Department of Gynecologic Oncology Surgery, Istituto Nazionale Tumori, IRCSS, "Fondazione G. Pascale", Naples, Italy s.greggi@istitutotumori.na.it.
作者：
Stefano,Greggi [1]
;
Francesca,Falcone [2]
;
Cono,Scaffa [2]
;
Andreas,du Bois [3]
;
Eleftherios Pierre Pierre,Samartzis [4]
;
Eric,Pujade-Lauraine [5]
;
David,Cibula [6]
;
Radoslaw,Mądry [7]
;
Jacob,Korach [8]
;
Kemal,Gungorduk [9]
;
Iain A,McNeish [10]
;
Vanna,Zanagnolo [11]
;
Christian,Marth [12]
;
Anne M,van Altena [13]
;
Gerasimos,Aravantinos [14]
;
Jalid,Sehouli [15]
;
Ignace,Vergote [16]
;
Antonio,Gonzalez Martin [17]
作者单位：
Multicentre Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) Group and Department of Gynecologic Oncology Surgery, Istituto Nazionale Tumori, IRCSS, "Fondazione G. Pascale", Naples, Italy s.greggi@istitutotumori.na.it.
[1]
Multicentre Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) Group and Department of Gynecologic Oncology Surgery, Istituto Nazionale Tumori, IRCSS, "Fondazione G. Pascale", Naples, Italy.
[2]
Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Group and Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte gGmbH, Essen, Germany.
[3]
Swiss Group for Clinical Cancer Research (SAKK) and Department of Gynecology, University Hospital Zurich, Zurich, Switzerland.
[4]
Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire, gynécologiques et du sein (GINECO) and Department of Medical Oncology, Hôpital Hôtel-Dieu, Université Paris Descartes, Paris, France.
[5]
Central and Eastern European Gynecologic Oncology Group (CEEGOG) and Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
[6]
Polish Gynecologic Oncology Group (PGOG) and Department of Gynecological Oncology, Poznan University of Medical Sciences, Poznan, Poland.
[7]
Israeli Society of Gynecologic Oncology (ISGO) and Department of Gynecologic Oncology, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Tel Aviv, Israel.
[8]
Turkish Society of Gynecologic Oncology (TRSGO) and Department of Gynecologic Oncology, Mugla Sitki Kocman University, Education and Research Hospital, Mugla, Turkey.
[9]
National Cancer Research Institute (NCRI) and Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
[10]
Mario Negri Gynecologic Oncology (MaNGO) Group and Department of Gynecologic Oncology, Istituto Europeo di Oncologia, Milan, Italy.
[11]
AGO-Austria and Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
[12]
Dutch Gynaecological Oncology Group (DGOG) and Department of Obstetrics and Gynecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
[13]
Ηellenic Cooperative Oncology Group (HeCOG) and Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece.
[14]
Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (NOGGO) and Department of Gynecologic Oncology, Charité Comprehensive Cancer Center Berlin, Berlin, Germany.
[15]
Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and Department of Gynecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium.
[16]
Grupo Español de Investigación en Cáncer de Ovario (GEICO) and Department of Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain.
[17]
DOI
10.1136/ijgc-2019-001172
PMID
32354792
发布时间
2025-04-28
换一批
